Shares of Arteris, Inc. (AIP) tumbled 13.46% on Tuesday following the release of the company's second-quarter 2025 financial results. The sharp decline comes as the semiconductor IP provider missed earnings estimates, despite announcing a partnership with Advanced Micro Devices (AMD).
For the second quarter, Arteris reported an adjusted loss per share of $0.11, falling short of analysts' expectations of $0.10. While the company's revenue grew 13% year-over-year to $16.5 million, slightly beating the consensus estimate of $16.35 million, the earnings miss appears to have overshadowed the top-line growth. The company also provided revenue guidance for the third quarter in the range of $16.8 million to $17.2 million, which may have disappointed investors.
Despite the negative reaction to earnings, Arteris announced a significant partnership with AMD, licensing its FlexGen smart network-on-chip IP for use in AMD's AI-focused chiplets. This news initially caused Arteris shares to jump 45.3% in pre-market trading. However, the excitement was short-lived as investors seemingly focused more on the company's current financial performance and near-term outlook. The stark contrast between the pre-market surge and the eventual plunge highlights the market's complex reaction to mixed news from the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.